Summary
Moderna shares surged 135% after its personalized mRNA cancer vaccine, combined with Keytruda, showed positive results in a late-stage trial for melanoma, significantly reducing recurrence and spread. This marks the first successful late-stage trial for an mRNA cancer vaccine, with regulatory discussions expected soon.
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostDescribe the story, headline, colors, and style you want.
Try Prompt to PostCombine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostUpload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostCombine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostTransform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostTurn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreAbout the public HyperFast News news feed powered by NewsEngine.
Purpose-built AI tools and business automation workflows for publishers, stores, agencies, and brands.
Products
© 2026 HyperFast. All Rights Reserved.
An initiative of Xzect Labs Private Limited
Moderna Cancer Vaccine Offers Hope, Urging Faster Personalized Therapy Development
19 Sept 2026, 8:28 pm · News
Moderna's Cancer Vaccine Cuts Melanoma Recurrence Risk in Early Trial
19 Sept 2026, 8:28 pm · News
Moderna, Merck Cancer Vaccine Achieves Breakthrough in Final-Stage Melanoma Trial
19 Sept 2026, 8:28 pm · News
Moderna's New Melanoma Vaccine: Mechanism and Potential for Other Cancers
19 Sept 2026, 8:28 pm · News
Understanding Moderna's New mRNA Cancer Vaccine for Melanoma
19 Sept 2026, 8:28 pm · News
Moderna pins hopes on 'game-changer' cancer vaccines with promising results
19 Sept 2026, 8:28 pm · News
